Sign In
Buy CC
$22.61
-0.640 (-2.75%)
At Close: Jun 03, 2026
Why Chemours Stock Is Up Big Today
01:18pm, Friday, 02'nd Jun 2023
Chemours, along with DuPont and Corteva, have reached a $1.185 billion settlement against charges they polluted groundwater. The case has been a major overhang for Chemours shares.
Chemours, DuPont, and Corteva shares rally after settlement deal in drinking water claims
10:43am, Friday, 02'nd Jun 2023
Chemours Company, DuPont (NYSE:DD) de Nemours, Inc, and Corteva, Inc have jointly announced a settlement agreement in principle to comprehensively resolve all per and polyfluoroalkyl substances (PFAS)
Chemours, DuPont and Corteva reach agreement to settle PFAS-related drinking water claims, but deny allegations
06:43am, Friday, 02'nd Jun 2023
The Chemours Co. CC, +2.34%, DuPont de Nemours Inc. DD, +0.37% and Corteva Inc. CTVA, +0.69% announced Friday an “agreement in principle” to settle all drinking water claims related to perfluoroal
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
07:30am, Wednesday, 31'st May 2023
While Chemours (CC) is exposed to headwinds from demand weakness in certain businesses, it gains on healthy Opteon adoption and its pricing actions.
Chemours (CC) Extends Capacity to Meet Customers' Needs
08:24am, Tuesday, 30'th May 2023
Chemours (CC) offers a portfolio of HFO-1336mzzZ-based products that are more environmentally friendly than non-HFO alternatives.
Chemours CEO on Semiconductor, EV Battery Demand
05:58pm, Tuesday, 02'nd May 2023
Chemours CEO Mark Newman, discusses the companies role in semiconductors and EV space. He says Chemours is committed to making chemistry responsibly and sees a large demand for its products despite op
Are Investors Undervaluing Chemours (CC) Right Now?
11:27am, Tuesday, 02'nd May 2023
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest
Chemours - There Is Upside After A Drop In Share Price
10:14pm, Friday, 28'th Apr 2023
Chemours is a company I've been covering for years. Challenges remain, but my long-term view for the business is a positive one. I maintain a position in CC. In this article, we'll do an update and se
The Chemours Company (CC) Q1 2023 Earnings Call Transcript
02:18pm, Friday, 28'th Apr 2023
The Chemours Company (NYSE:CC ) Q1 2023 Results Conference Call April 28, 2023 8:00 AM ET Company Participants Jonathan Lock - SVP and Chief Development Officer Mark Newman - CEO, President and Direct
Chemours (CC) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
10:47pm, Thursday, 27'th Apr 2023
While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to
Chemours (CC) Surpasses Q1 Earnings Estimates
07:00pm, Thursday, 27'th Apr 2023
Chemours (CC) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $1.46 per share a year ago.
Chemours Announces Dates for First Quarter 2023 Earnings Release and Webcast Conference Call
05:29pm, Thursday, 06'th Apr 2023
WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions,
7 Super Speculative Meme Stocks That Could Make You Very Rich
03:18pm, Thursday, 06'th Apr 2023
If the Covid-19 pandemic taught us anything, it's that investors should never underestimate the power of coordinated trading action via social media, which brings up the topic of super speculative mem
Here's Why You Should Hold Onto Chemours (CC) Stock for Now
01:44pm, Tuesday, 28'th Mar 2023
While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand and its pricing actions.
The chemical industry is critical to advanced electronics, says Chemours CEO
07:22pm, Thursday, 16'th Feb 2023
Mark Newman, CEO of chemical company Chemours, joins Brian Sullivan and the 'CNBC Special: Taking Stock' to discuss how his company is working to expand the footprint of American manufacturing.
